» Articles » PMID: 36125535

Secretome Analysis Reveals Reduced Expression of COL4A2 in Hypoxic Cancer-associated Fibroblasts with a Tumor-promoting Function in Gastric Cancer

Overview
Specialty Oncology
Date 2022 Sep 20
PMID 36125535
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cancer-associated fibroblasts (CAFs) are major components of the tumor microenvironment (TME). Hypoxic TME is known to promote tumor progression. However, how a hypoxic condition regulates CAFs remains elusive.

Methods: To investigate the underlying mechanism involved in the regulation of gastric cancer (GC) progression by hypoxic CAFs, we performed secretome profiling. Normoxic or hypoxic CAFs conditioned media (CM) were filter-concentrated and in-gel trypsin digested. Resulting peptides were analyzed with LC-MS/MS.

Results: We observed that CM derived from hypoxic CAFs could promote migration of a panel of GC cell lines (AGS, SNU668, SNU638). Mass spectrometry analysis of hypoxic or normoxic CAFs CM identified 1595 proteins, of which 19 proteins (10 upregulated and 9 downregulated) were differentially expressed in the hypoxic secretome. We focused on COL4A2, whose expression was significantly decreased in hypoxic CAFs in HIF-1α-independent manner. Silencing of COL4A2 expression in normoxic CAFs phenocopied the effect of hypoxic CAFs in promoting GC cell migration.

Conclusions: The reduced expression of COL4A2 in a hypoxic environment might be associated with the tumor-promoting role of hypoxic CAFs in GC.

Citing Articles

COL4A2 enhances thyroid cancer cell proliferation through the AKT pathway.

He L, Han W, Yue K, Wang X Oncol Res. 2024; 32(9):1467-1478.

PMID: 39220121 PMC: 11361908. DOI: 10.32604/or.2024.047382.


Activity-based protein profiling and global proteome analysis reveal MASTL as a potential therapeutic target in gastric cancer.

Choi K, Kim S, Ji M, Kim E, Kim J, Park H Cell Commun Signal. 2024; 22(1):397.

PMID: 39138495 PMC: 11323684. DOI: 10.1186/s12964-024-01783-8.


Cancer-associated fibroblasts: protagonists of the tumor microenvironment in gastric cancer.

Ozmen E, Demir T, Ozcan G Front Mol Biosci. 2024; 11:1340124.

PMID: 38562556 PMC: 10982390. DOI: 10.3389/fmolb.2024.1340124.


Characterization of gastric cancer-stimulated signaling pathways and function of CTGF in cancer-associated fibroblasts.

Choi K, Kim B, Lee S, Han J, Bae H, Han S Cell Commun Signal. 2024; 22(1):8.

PMID: 38167009 PMC: 10763493. DOI: 10.1186/s12964-023-01396-7.


Secretome of Stromal Cancer-Associated Fibroblasts (CAFs): Relevance in Cancer.

Mishra D, Banerjee D Cells. 2023; 12(4).

PMID: 36831295 PMC: 9953839. DOI: 10.3390/cells12040628.

References
1.
Al Tameemi W, Dale T, Al-Jumaily R, Forsyth N . Hypoxia-Modified Cancer Cell Metabolism. Front Cell Dev Biol. 2019; 7:4. PMC: 6362613. DOI: 10.3389/fcell.2019.00004. View

2.
Bai Y, Kim J, Watters J, Fang B, Kinose F, Song L . Adaptive responses to dasatinib-treated lung squamous cell cancer cells harboring DDR2 mutations. Cancer Res. 2014; 74(24):7217-7228. PMC: 4326029. DOI: 10.1158/0008-5472.CAN-14-0505. View

3.
Benjamini Y, Heller R, Yekutieli D . Selective inference in complex research. Philos Trans A Math Phys Eng Sci. 2009; 367(1906):4255-71. PMC: 3263782. DOI: 10.1098/rsta.2009.0127. View

4.
Chang Y, Kong G, Sun S, Liu D, El-Naggar A, Khuri F . Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer. Clin Cancer Res. 2002; 8(12):3796-802. View

5.
Chen W, Huang C, Wu M, Yang S, Su Y, Chai C . Hypoxia-inducible factor-1alpha is associated with risk of aggressive behavior and tumor angiogenesis in gastrointestinal stromal tumor. Jpn J Clin Oncol. 2005; 35(4):207-13. DOI: 10.1093/jjco/hyi067. View